- Contractors
- AN2 Therapeutics, Inc
AN2 Therapeutics, Inc
Federal contractor · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
AN2 Therapeutics has 1 federal contract of $100,000 or more active since October 2023, with $9.24M obligated, from 1 agency. 1 is still running, 1 ending within 18 months.
- Contracts
- 1 since FY2024$9,235,577 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- National Institutes of Health$9.24M on 1 contract
- UEI
- DD4FE2GE4L78Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Development of Epetraborole As a Novel Therapeutic for Melioidosis and Additional Antimicrobial Resistant (Amr) Bacterial Biothreat Pathogens.National Institutes of Health · 75N93022C00059 | $9,235,577 | Jul 31, 2027in 8 months | CA |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| National Institutes of Health1 contract | $9,235,577 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 · 1 contract | $9,235,577 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| California1 contract | $9,235,577 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.
Get new notices like AN2 Therapeutics's work
New contract opportunities under NAICS 541715, research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy